Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohammad Hussein

Showing results (181-190 of 193) with videos related to

Pageof 20
Sort By:
The Journal of International Medical Research|May 14, 2025
Dual antiplatelet therapy versus aspirin alone in acute ischemic stroke or transient ischemic attack: A meta-analysis and trial sequential analysis of randomized controlled trialsRamez M Odat, Sakhr Alshwayyat, Zainab I Bahdar, et al.
BMC Neurology|November 28, 2024
Risk of stroke in patients with congenital heart disease: a systematic review and meta-analysisRamez M Odat, Muhammad Idrees, Hritvik Jain, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 4, 2026
A comparison of sensitivity and specificity of dosimetry audits for intensity modulated radiation therapy used internationally for clinical trial credentialingFre'Etta Brooks, Joerg Lehmann, Mohammad Hussein, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 20, 2021
Report dose-to-medium in clinical trials where available; a consensus from the Global Harmonisation Group to maximize consistencyStephen F Kry, Jessica Lye, Catharine H Clark, et al.
Cancer Management and Research|December 5, 2018
Deletion of 3p13 is a late event linked to progression of <i>TMPRSS2</i>:<i>ERG</i> fusion prostate cancerMartina Kluth, Heinke Volta, Mohammad Hussein, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 3, 2024
Technical recommendations for implementation of Volumetric Modulated Arc Therapy and Helical Tomotherapy Total Body IrradiationEnrica Seravalli, Mirjam E Bosman, Chunhui Han, et al.
Vaccine: X|May 15, 2024
Presenting clinical symptoms of post-COVID-19 breakthrough infection: Predictors of mortality in a Middle Eastern populationAsma S Albtoosh, Randa Farah, Khaled Al Oweidat, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 24, 2022
SEAFARER - A new concept for validating radiotherapy patient specific QA for clinical trials and clinical practiceJoerg Lehmann, Mohammad Hussein, Miriam A Barry, et al.
Oncotarget|March 23, 2019
A nuclear shift of GSK3β protein is an independent prognostic factor in prostate cancerTill Eichenauer, Mohammad Hussein, Claudia Hube-Magg, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 22, 2026
It's not your device, it's how you use it - Sensitivity and specificity of PSQA devices in the SEAFARER head and neck studyLauren May, José Antonio Baeza-Ortega, Mohammad Hussein, et al.
Pageof 20

Showing results (181-190 of 193) with videos related to

Sort By:
Pageof 20
The Journal of International Medical Research|May 14, 2025
Dual antiplatelet therapy versus aspirin alone in acute ischemic stroke or transient ischemic attack: A meta-analysis and trial sequential analysis of randomized controlled trialsRamez M Odat, Sakhr Alshwayyat, Zainab I Bahdar, et al.
BMC Neurology|November 28, 2024
Risk of stroke in patients with congenital heart disease: a systematic review and meta-analysisRamez M Odat, Muhammad Idrees, Hritvik Jain, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 4, 2026
A comparison of sensitivity and specificity of dosimetry audits for intensity modulated radiation therapy used internationally for clinical trial credentialingFre'Etta Brooks, Joerg Lehmann, Mohammad Hussein, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 20, 2021
Report dose-to-medium in clinical trials where available; a consensus from the Global Harmonisation Group to maximize consistencyStephen F Kry, Jessica Lye, Catharine H Clark, et al.
Cancer Management and Research|December 5, 2018
Deletion of 3p13 is a late event linked to progression of <i>TMPRSS2</i>:<i>ERG</i> fusion prostate cancerMartina Kluth, Heinke Volta, Mohammad Hussein, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 3, 2024
Technical recommendations for implementation of Volumetric Modulated Arc Therapy and Helical Tomotherapy Total Body IrradiationEnrica Seravalli, Mirjam E Bosman, Chunhui Han, et al.
Vaccine: X|May 15, 2024
Presenting clinical symptoms of post-COVID-19 breakthrough infection: Predictors of mortality in a Middle Eastern populationAsma S Albtoosh, Randa Farah, Khaled Al Oweidat, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 24, 2022
SEAFARER - A new concept for validating radiotherapy patient specific QA for clinical trials and clinical practiceJoerg Lehmann, Mohammad Hussein, Miriam A Barry, et al.
Oncotarget|March 23, 2019
A nuclear shift of GSK3β protein is an independent prognostic factor in prostate cancerTill Eichenauer, Mohammad Hussein, Claudia Hube-Magg, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 22, 2026
It's not your device, it's how you use it - Sensitivity and specificity of PSQA devices in the SEAFARER head and neck studyLauren May, José Antonio Baeza-Ortega, Mohammad Hussein, et al.
Pageof 20